1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Vitamin Shoppe's Buyer Took Tumultuous Path Toward Recent Turn To Investing

 
• By Malcolm Spicer

Liberty Tax, which owns tax-return preparation business Liberty Tax Services and branched into capital investing in July, agrees to pay $6.50 per Vitamin Shoppe share, a 43% premium on its closing price a day earlier. Vitamin Shoppe's earnings struggles continued in Q2 as total sales fell 7.6% to $270.9m and it reported a $3.6m net loss after generating $5.3m net income a year ago.

The words Time To Sell in white text on a blackboard next to a modern wall clock as a reminder - Image

[Vitamin Shoppe Inc.] has been looking to stop a steady decline in earnings for five years. Liberty Tax Inc., on the other hand, needed less than a month since moving from operating a tax-preparation service chain to also buying out firms in unrelated sectors before making an offer for the second-largest US vitamin, mineral and supplement retailer.

The firms on 8 August announced a cash transaction valued at around $208m with Liberty Tax, which owns Liberty Tax Services, paying $6.50 per Vitamin Shoppe share, a 43% premium on its closing price the day before and a premium of around 59% on the volume-weighted average price for the previous 30 days

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Haleon Utilizing AI To Develop Natural CHC Products

 
• By Tom Gallen

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By Tom Gallen

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.

Astaxanthin Specialist AstaReal Diversifies With Garlic Supplement For Heart Health

 
• By Tom Gallen

Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

More from Business

C&D Divesting Flawless, Spinbrush Lines, Says Gummy Vitamin Brands Might Not Stick

 
• By Malcolm Spicer

C&D reports Q1 net sales dropped 2.4% to $1.48bn, below its guidance for around 1% growth. Its brands’ sales at retail and market share grew in the quarter, but “experienced slowing category growth in the US market” as retailers reduced inventory levels.

Herbalife Expects No ‘Material’ Impact From China Tariff, Recent Deals To Bring ‘New Era’ Of Growth

 
• By Malcolm Spicer

Herbalife expects little impact from increased tariffs on imports from China but strong boosts from acquiring Pro2col Health and Pruvit Ventures Inc. and 51% ownership of Link BioSciences.

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By Tom Gallen

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.